Lv1
80 积分 2022-08-08 加入
HER2-Low Gastric and Gastroesophageal Junction Adenocarcinoma: From Assessment to Treatment Strategies
1个月前
已完结
Claudin 18.2 testing in gastroesophageal and pancreatobiliary cancers: current status, clinical implications and challenges
1个月前
已完结
Atezolizumab and Trastuzumab Plus Chemotherapy for ERBB2-Positive Locally Advanced Resectable Gastric Cancer
2个月前
已完结
Diagnostic discordance and treatment-associated change of PD-L1 and CLDN18.2 in gastric cancer: a real-world analysis of paired biopsy–resection samples
2个月前
已完结
Efficacy and safety of anti-CLDN18.2 therapies in advanced or metastatic gastric, gastro-oesophageal junction, and oesophageal carcinomas with CLDN18.2 positivity: a systematic review and meta-analysis
2个月前
已关闭
Identification of factors conferring resistance to trastuzumab deruxtecan in advanced gastric cancer: a translational study from the single-arm, phase II, DESTINY-Gastric06 trial
5个月前
已完结
皖公网安备34019202002308
